Skip to main content
Cancer Explained
Donate
Beginner 6 min readSource checked

Cutaneous T-Cell Lymphoma: Treatment Options

How to discuss cutaneous t-cell lymphoma treatment goals, benefits, risks, specialists, supportive care, and clinical trials.

This is general education — it cannot tell you what to do in your situation.

Instructions and urgent-contact thresholds vary by treatment and care team. If you are in treatment, follow the instructions your oncology team gave you, and contact them about any new or worsening symptom. If you think you may be having a medical emergency, call your local emergency number.

NCI source

NCI PDQ — Mycosis Fungoides (Including Sézary Syndrome) Treatment (Patient Version)

A woman laughs with a nurse during an infusion, IV line visible
A woman laughs with a nurse during an infusion, IV line visible

Key fact

Mycosis fungoides and Sézary syndrome are the two main forms; in Sézary syndrome the cancer cells also circulate in the blood.

The short answer

Cutaneous T-cell lymphoma is treated by matching intensity to how much of the body is affected: creams and bexarotene for limited skin disease, PUVA or photopheresis, total skin electron beam radiation, and systemic drugs such as HDAC inhibitors or mogamulizumab for advanced disease.

  • Mycosis fungoides and Sézary syndrome are the two main forms; in Sézary syndrome the cancer cells also circulate in the blood.

  • Limited skin disease often starts with topical corticosteroids or the retinoid bexarotene, which cause fewer body-wide side effects.

  • Light-based options are PUVA, which pairs psoralen with ultraviolet A, and extracorporeal photopheresis, which NCI says can be used alone or with total skin electron beam radiation.

  • Systemic options NCI lists include chemotherapy, interferon, the HDAC inhibitors vorinostat and romidepsin, and the antibody mogamulizumab, which binds the CCR4 protein.

Choose how you want to understand this

The full explanation.

The short answer

Cutaneous T-cell lymphoma is a lymphoma that affects your skin. Mycosis fungoides and Sézary syndrome are its two main forms. In Sézary syndrome, cancerous cells are also found circulating in your blood, not just your skin. Treatment ranges from skin-directed therapies for early disease to systemic drugs for more advanced or widespread disease. Your team will match the intensity of treatment to how much of your body is affected.

How the disease shows up on your skin

This lymphoma typically moves through stages on the skin. It can start as flat patches. It can progress to raised plaques. In some cases, it develops into tumors. Sézary syndrome causes widespread skin redness. It also comes with a high number of cancer cells in your blood. Knowing which stage and pattern you have shapes almost every treatment decision that follows.

Treatments applied directly to the skin

For early or limited disease, treatment often starts on the skin itself. Corticosteroid creams calm inflammation. A retinoid medicine called bexarotene, also available as a gel, can slow the growth of cancer cells in the skin. These topical options usually cause fewer body-wide side effects than systemic drugs. This is one reason they are often tried first for limited disease.

Light-based treatments

PUVA therapy combines a light-sensitizing drug called psoralen with ultraviolet A light exposure. Another approach, called extracorporeal photopheresis, removes some of your blood cells. It exposes them to UV light outside your body, then returns them to you. This can be used alone. It can also be combined with radiation therapy aimed at your entire skin surface.

Radiation therapy

Total skin electron beam therapy delivers radiation across your entire skin surface. It is useful when disease is widespread on the skin. Localized radiation can target one specific lesion instead, when that is all that needs treatment. Ask your team which approach fits the extent of your disease.

Systemic treatments for more advanced disease

Systemic options come into play when disease is more advanced. They are also used when disease has not responded to skin-directed treatments. These include chemotherapy drugs, and interferon, an immune-modulating treatment. HDAC inhibitors like vorinostat and romidepsin are options too. They affect how cancer cells regulate their own genes. Mogamulizumab is a monoclonal antibody, a lab-made immune protein. It attaches to a specific marker on some lymphoma cells. This helps your immune system attack them.

Newer options being studied

Immune checkpoint inhibitors, including pembrolizumab, are being tested in clinical trials for cutaneous T-cell lymphoma. These work by helping your own immune system recognize and attack cancer cells more effectively. Ask your team whether a clinical trial might be a reasonable option for your specific situation.

Side effects worth planning for

Skin-directed treatments commonly cause irritation, redness, or dryness at the treated area. Systemic drugs bring a wider range of possible side effects. These include fatigue and effects on blood counts, and they vary by which specific drug you receive. Ask your team what to expect from your particular treatment plan. This disease's treatments vary more than most.

Which symptoms cannot wait

A fever of 100.4°F (38°C) or higher is the threshold CDC gives for infection during cancer treatment. Ring your care team as soon as you record it, at any hour rather than waiting for office hours. If you are on chemotherapy or another systemic drug that pushes your blood counts down, treat that reading as a medical emergency: it may be the only sign of an infection that needs treating within hours. Should you not get through to the team quickly, head for an emergency department and say on arrival that you are being treated for lymphoma. Ask your team which group your own treatment puts you in. Also call for widespread skin breakdown, or signs of skin infection such as increasing warmth, redness, or drainage. Sudden worsening of your rash needs a same-day call too. These need prompt evaluation, not a wait for your next scheduled visit.

What to ask your care team

  • What stage and pattern of cutaneous T-cell lymphoma do I have?
  • Would skin-directed treatment, light therapy, radiation, or a systemic drug fit my situation best?
  • What side effects should I expect from my specific treatment, and which need a same-day call?
  • Is a clinical trial a reasonable option for me?

Sources

Words to know

Tap any term to see what it means.

Browse the full glossary →

Two women sit at a table organizing pill bottles and medication

Common questions

What is cutaneous T-cell lymphoma?

It is a lymphoma that affects your skin. Mycosis fungoides and Sézary syndrome are its two main forms. In Sézary syndrome, cancerous cells are also found circulating in your blood, not just in your skin.

Why do some people get creams and others get drugs?

Your team matches the intensity of treatment to how much of your body is affected. For early or limited disease, treatment often starts on the skin itself, with corticosteroid creams to calm inflammation or bexarotene, a retinoid medicine also available as a gel. Topical options usually cause fewer body-wide side effects, which is why they are often tried first.

What do the light-based treatments involve?

PUVA therapy combines a light-sensitizing drug called psoralen with ultraviolet A light exposure. Extracorporeal photopheresis removes some of your blood cells, exposes them to UV light outside your body, then returns them. Photopheresis can be used alone, or combined with radiation aimed at your entire skin surface.

What systemic treatments are used for more advanced disease?

Chemotherapy drugs and interferon, an immune-modulating treatment. HDAC inhibitors such as vorinostat and romidepsin affect how cancer cells regulate their own genes. Mogamulizumab is a monoclonal antibody, a lab-made immune protein, that attaches to a specific marker on some lymphoma cells and helps your immune system attack them.

Which symptoms cannot wait for the next visit?

A fever of 100.4°F (38°C) or higher is the threshold CDC gives for infection during cancer treatment, so ring your care team as soon as you record it, at any hour. If your treatment is chemotherapy, or another systemic drug your team has said lowers your blood counts, that reading is a medical emergency; if you cannot reach the team quickly, go to an emergency department and tell them you are being treated for lymphoma. Also call for widespread skin breakdown, or signs of skin infection such as increasing warmth, redness or drainage. Sudden worsening of your rash needs a same-day call too.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this guide into a short list for your care team.

Build questions for your visit
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-20Next planned review: 2027-01-22

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Still have questions?

Educational answers, plain language

Ask Cancer Explained

Doctor Visit Prep Tool

Get a personalized list of questions to ask about this topic.

Start the guide